Abstract
Full length human C1 inhibitor cDNA was cloned into a vector suitable for transient expression in COS-1 cells. Transfected COS cells secreted an immunoreactive protein of Mr approximately 110,000 that appeared to be functionally equivalent to the plasma-derived protein as established by the following criteria: 1) ability to form sodium dodecyl sulfate-stable complexes with C1s, factor XIIa, and kallikrein; 2) inhibition of C1s-mediated C4 consumption; and 3) susceptibility to inactivation by the nontarget proteinase elastase. Quantitation of secreted recombinant C1 inhibitor by radioimmunoassay indicated that 72 h after transfection the level was approximately 2.2 micrograms/ml. Treatment of transfected cells with tunicamycin resulted in secretion of a protein of Mr approximately 90,000 that was also capable of complex formation with C1s.
MeSH terms
-
Animals
-
Cell Line
-
Complement C1 Inactivator Proteins / genetics*
-
Complement C1 Inactivator Proteins / metabolism
-
Complement C1 Inactivator Proteins / pharmacology
-
Complement C1s / metabolism
-
Complement C4 / metabolism
-
DNA / genetics
-
DNA, Recombinant
-
Electrophoresis, Polyacrylamide Gel
-
Factor XII / metabolism
-
Factor XIIa
-
Haplorhini
-
Humans
-
Immunoassay
-
Kallikreins / metabolism
-
Pancreatic Elastase / pharmacology
-
Recombinant Proteins / genetics*
-
Recombinant Proteins / metabolism
-
Recombinant Proteins / pharmacology
-
Serine Endopeptidases / metabolism
-
Simian virus 40 / genetics
-
Transcription, Genetic
-
Transfection
-
Tunicamycin / pharmacology
Substances
-
Complement C1 Inactivator Proteins
-
Complement C4
-
DNA, Recombinant
-
Recombinant Proteins
-
Tunicamycin
-
Factor XII
-
DNA
-
Kallikreins
-
Serine Endopeptidases
-
Pancreatic Elastase
-
Factor XIIa
-
Complement C1s